Why Lasers Do Not Cure Melasma, and What They Can Actually Do

Walk into almost any consultation room along the Wilshire corridor and you will hear a version of the same question: which laser gets rid of melasma? It is a reasonable question, since lasers reliably clear sunspots, tattoos, and many vascular lesions. But melasma is a different biological problem, and the honest answer, supported by dermatology literature and by the clinicians who treat it daily, is that no laser cures melasma. Some devices can help manage it. Several can aggravate it. Understanding why requires looking at what melasma actually is.

Melasma is a hormonally driven, light sensitive pigment disorder, not a spot. A sunspot, technically a solar lentigo, is a discrete cluster of pigment that a pigment selective laser can target and clear, often permanently. Melasma involves overactive melanocytes spread across the face, typically the cheeks, forehead, and upper lip, that respond to ultraviolet light, visible light, heat, estrogen, and inflammation by producing more pigment. The melanocytes themselves are not destroyed by treatment, and they retain their hair trigger behavior afterward. That is why melasma is described as a chronic, relapsing condition. Any treatment, laser or otherwise, is management rather than cure. For an independent overview, see Melasma and pigmentation: diagnosis and treatment.

Heat is the central problem. Most pigment lasers work through selective photothermolysis: the laser wavelength is absorbed by melanin, converting light into heat that damages the pigment or the cell carrying it. In melasma, that heat is a double edged sword. Thermal energy is itself a trigger for melanocyte activation. Deliver too much of it and you can provoke post inflammatory hyperpigmentation, meaning the treated area comes back darker than before. This is the mechanism behind the familiar melasma rebound, where a patient looks clearer at two weeks and worse at eight. It is also why traditional intense pulsed light and older Q-switched protocols at standard fluences have a poor track record for melasma, particularly in Fitzpatrick skin types III to VI, which make up a large share of the Los Angeles patient population.

What the low energy approaches actually do. The devices most commonly used for melasma in Beverly Hills practices today fall into a few categories, each with a distinct rationale. Low fluence 1064 nm Q-switched treatments, often marketed as laser toning, use many gentle passes to fragment pigment while keeping thermal load low. Picosecond lasers push in the same direction: their extremely short pulses shatter pigment mostly through photoacoustic, or pressure based, effects rather than heat, which in principle reduces the inflammatory trigger. Non-ablative fractional lasers at 1927 nm create microscopic channels that accelerate turnover of pigment laden skin. All three can lighten melasma. None of them switches off the melanocytes, so maintenance is expected, and even conservative settings carry rebound risk if intervals are too short or energies creep up.

Topicals and sun behavior do the heavy lifting. In published treatment algorithms, lasers sit in the third or fourth line, behind rigorous photoprotection and topical therapy. Tinted mineral sunscreen matters more than most patients expect, because iron oxides block the visible light wavelengths that stimulate melasma and that ordinary chemical sunscreens do not filter. Hydroquinone, often compounded into a triple combination cream with tretinoin and a mild steroid, remains the topical benchmark. Oral tranexamic acid, prescribed off label in appropriate candidates after screening for clotting risk, has become a common adjunct precisely because it addresses one of melasma's drivers, the interaction between skin cells and small blood vessels, that no laser touches. A laser used without this foundation is treating the smoke and ignoring the fire.

Questions worth asking before any melasma laser session. First, ask how the practice confirms the diagnosis, since melasma is sometimes confused with post inflammatory pigment or lentigines, and the treatment implications differ. Many clinicians use a Wood's lamp or discuss whether pigment appears epidermal, dermal, or mixed, because deeper pigment responds less predictably. Second, ask what happens if you darken after treatment, and what the plan is for spacing sessions, which is typically two to four weeks apart at conservative energies. Third, ask whether you will be on topical therapy and strict photoprotection before the first pulse fires. A practice that begins lasering melasma at the first visit, without a topical run in, is skipping the step with the strongest evidence.

The bottom line. Lasers are legitimate tools in melasma management, particularly low fluence 1064 nm, picosecond, and gentle 1927 nm fractional protocols in experienced hands. What they are not is a cure, and any pitch promising permanent clearance in a set number of sessions is describing a result the biology does not support. The patients who do best treat melasma the way clinicians describe it: a chronic condition controlled through daily photoprotection, topical therapy, sometimes oral medication, and occasional carefully dosed light, in that order.

Related reading: Can Laser Make Melasma Worse? A Myth Check.